BeOne Medicines Ltd. (ONC)

299.78 -2.66 (-0.88%) USD  |  NASDAQ  |  May 27, 16:00
299.78 0.00 (0.00%) After-Hours: 16:40
More

BeOne Medicines EPS Diluted (Quarterly) : 1.970 for March 31, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for ONC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Kuros Biosciences Ltd. --
Basilea Pharmaceutica AG --
Santhera Pharmaceuticals Holding AG --
AC Immune SA -0.1914
CRISPR Therapeutics AG -1.280

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) 228.03M
Revenue (Quarterly) 1.518B
Total Expenses (Quarterly) 1.290B
Enterprise Value 28.60B
Gross Profit Margin (Quarterly) 86.63%
Profit Margin (Quarterly) 15.02%
Earnings Yield 1.49%
Operating Earnings Yield 2.00%
Normalized Earnings Yield 1.615